{
 "PrintNo":"A9188","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2024-02-12T10:33:58.044044Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-02-12","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2024-02-12","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Adds tianeptine sodium to the list of Schedule II of controlled substances",
 "Summary":"Adds tianeptine sodium to list of Schedule II of controlled substances.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances",
 "SameAsPrintNo":"S1720-2023","PreviousVersions":["A7550-2019","A344-2021"]
}